NO173276C - Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater - Google Patents

Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater

Info

Publication number
NO173276C
NO173276C NO885224A NO885224A NO173276C NO 173276 C NO173276 C NO 173276C NO 885224 A NO885224 A NO 885224A NO 885224 A NO885224 A NO 885224A NO 173276 C NO173276 C NO 173276C
Authority
NO
Norway
Prior art keywords
group
disubstituted
therapeutically active
analogous process
positions
Prior art date
Application number
NO885224A
Other languages
English (en)
Other versions
NO885224L (no
NO885224D0 (no
NO173276B (no
Inventor
Albert A Carr
Thaddeus R Nieduzak
Francis P Miller
Stephen M Sorensen
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO885224D0 publication Critical patent/NO885224D0/no
Publication of NO885224L publication Critical patent/NO885224L/no
Publication of NO173276B publication Critical patent/NO173276B/no
Publication of NO173276C publication Critical patent/NO173276C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
NO885224A 1987-11-24 1988-11-23 Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater NO173276C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12469287A 1987-11-24 1987-11-24
US07/254,208 US4870083A (en) 1987-11-24 1988-10-11 1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants

Publications (4)

Publication Number Publication Date
NO885224D0 NO885224D0 (no) 1988-11-23
NO885224L NO885224L (no) 1989-05-25
NO173276B NO173276B (no) 1993-08-16
NO173276C true NO173276C (no) 1993-12-01

Family

ID=26822854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885224A NO173276C (no) 1987-11-24 1988-11-23 Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater

Country Status (17)

Country Link
US (1) US4870083A (no)
EP (1) EP0317997B1 (no)
JP (1) JP2835730B2 (no)
KR (1) KR0143091B1 (no)
CN (1) CN1019974C (no)
AT (1) ATE107282T1 (no)
AU (1) AU615494B2 (no)
CA (1) CA1330086C (no)
DE (1) DE3850222T2 (no)
DK (1) DK653788A (no)
ES (1) ES2056876T3 (no)
FI (1) FI885391A (no)
HU (1) HU199793B (no)
IL (1) IL88415A0 (no)
NO (1) NO173276C (no)
PH (1) PH25428A (no)
PT (1) PT89064B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5162342A (en) * 1988-01-21 1992-11-10 Merrell Dow Pharmaceuticals Inc. Use of 1,4-disubstituted-piperidinyl compounds for analgesia and muscle relaxation
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB2418889B (en) * 2004-10-05 2006-10-04 Sumitomo Chemical Co Laminated product and process for producing the same
GB0519879D0 (en) 2005-09-30 2005-11-09 Astrazeneca Ab Chemical process
MX2008014450A (es) 2006-05-18 2009-03-09 Mannkind Corp Inhibidores de cinasa intracelular.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4034527Y1 (no) * 1964-04-09 1965-12-03
FR2092133B1 (no) * 1970-05-06 1974-03-22 Orsymonde
US3852455A (en) * 1970-11-27 1974-12-03 Richardson Merrell Inc 4-{8 4({60 hydroxybenzyl)piperidino{9 -4-fluorobutyrophenone derivatives as tranquilizers
US3888867A (en) * 1972-05-03 1975-06-10 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)4'-fluorobutyrophenone derivatives
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
JPS532474A (en) * 1976-06-26 1978-01-11 Yoshitomi Pharmaceut Ind Ltd Aminoketone derivatives
JPS59217335A (ja) * 1983-05-25 1984-12-07 Toshiba Corp 半導体装置
JPS612662A (ja) * 1984-06-15 1986-01-08 Matsushita Electric Ind Co Ltd 原稿給送装置
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
JPH06950B2 (ja) * 1985-07-26 1994-01-05 石川島播磨重工業株式会社 イオンプレ−テイング装置
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체

Also Published As

Publication number Publication date
KR890008095A (ko) 1989-07-08
PT89064A (pt) 1988-12-01
JPH02138174A (ja) 1990-05-28
JP2835730B2 (ja) 1998-12-14
DE3850222D1 (de) 1994-07-21
EP0317997A2 (en) 1989-05-31
ATE107282T1 (de) 1994-07-15
KR0143091B1 (ko) 1998-07-15
NO885224L (no) 1989-05-25
FI885391A (fi) 1989-05-25
PT89064B (pt) 1993-04-30
AU2572488A (en) 1989-05-25
FI885391A0 (fi) 1988-11-21
NO885224D0 (no) 1988-11-23
EP0317997A3 (en) 1990-10-10
US4870083A (en) 1989-09-26
AU615494B2 (en) 1991-10-03
CA1330086C (en) 1994-06-07
HUT48586A (en) 1989-06-28
DK653788D0 (da) 1988-11-23
IL88415A0 (en) 1989-06-30
EP0317997B1 (en) 1994-06-15
HU199793B (en) 1990-03-28
NO173276B (no) 1993-08-16
CN1019974C (zh) 1993-03-03
DE3850222T2 (de) 1994-09-22
CN1034202A (zh) 1989-07-26
PH25428A (en) 1991-07-01
DK653788A (da) 1989-05-25
ES2056876T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
ZW3690A1 (en) Treatment and compounds
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
ATE243209T1 (de) Tetrahydro gamma-carboline
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
NO173276C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater
FI915653A (fi) 5-amino-5,6,7,8-tetrahydroquinoliner och beslaektade foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ES8200661A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.